Lingohr & Partner Asset Management GmbH bought a new position in shares of Mallinckrodt PLC (NYSE:MNK) in the 1st quarter, HoldingsChannel reports. The institutional investor bought 15,470 shares of the company’s stock, valued at approximately $332,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Great West Life Assurance Co. Can lifted its stake in shares of Mallinckrodt by 22.6% during the 1st quarter. Great West Life Assurance Co. Can now owns 69,807 shares of the company’s stock worth $1,515,000 after buying an additional 12,890 shares during the last quarter. 361 Capital LLC bought a new position in Mallinckrodt during the first quarter worth about $2,530,000. LSV Asset Management increased its position in Mallinckrodt by 1.4% during the first quarter. LSV Asset Management now owns 4,149,268 shares of the company’s stock worth $90,205,000 after acquiring an additional 58,300 shares during the period. Mason Street Advisors LLC increased its position in Mallinckrodt by 1.8% during the first quarter. Mason Street Advisors LLC now owns 44,405 shares of the company’s stock worth $965,000 after acquiring an additional 765 shares during the period. Finally, Affinity Investment Advisors LLC increased its position in Mallinckrodt by 23.9% during the first quarter. Affinity Investment Advisors LLC now owns 18,651 shares of the company’s stock worth $405,000 after acquiring an additional 3,597 shares during the period.

MNK stock opened at $9.10 on Friday. The company has a debt-to-equity ratio of 1.90, a quick ratio of 1.08 and a current ratio of 1.45. Mallinckrodt PLC has a 12 month low of $8.45 and a 12 month high of $36.65. The stock has a market capitalization of $827.24 million, a price-to-earnings ratio of 1.14, a PEG ratio of 0.10 and a beta of 2.12.

Mallinckrodt (NYSE:MNK) last released its earnings results on Tuesday, May 7th. The company reported $1.94 EPS for the quarter, beating the consensus estimate of $1.73 by $0.21. Mallinckrodt had a negative net margin of 118.53% and a positive return on equity of 14.22%. The firm had revenue of $791.00 million for the quarter, compared to analyst estimates of $766.27 million. During the same period last year, the firm earned $1.31 EPS. The business’s quarterly revenue was up 4.7% compared to the same quarter last year. Equities research analysts forecast that Mallinckrodt PLC will post 8.38 earnings per share for the current fiscal year.

A number of equities analysts recently commented on MNK shares. Canaccord Genuity set a $40.00 price target on shares of Mallinckrodt and gave the stock a “buy” rating in a research report on Monday, March 18th. Morgan Stanley set a $32.00 price target on shares of Mallinckrodt and gave the stock a “hold” rating in a research report on Thursday, February 28th. Mizuho raised their price target on shares of Mallinckrodt to $26.00 and gave the stock a “neutral” rating in a research report on Thursday, February 28th. ValuEngine raised shares of Mallinckrodt from a “sell” rating to a “hold” rating in a research report on Monday, February 4th. Finally, SunTrust Banks started coverage on shares of Mallinckrodt in a research report on Tuesday, March 19th. They set a “hold” rating and a $23.00 price target on the stock. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $26.72.

ILLEGAL ACTIVITY NOTICE: This report was posted by Watch List News and is the property of of Watch List News. If you are reading this report on another publication, it was copied illegally and republished in violation of US and international trademark and copyright law. The original version of this report can be viewed at https://www.watchlistnews.com/lingohr-partner-asset-management-gmbh-invests-332000-in-mallinckrodt-plc-mnk-stock/3020999.html.

Mallinckrodt Company Profile

Mallinckrodt plc, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands, and Specialty Generics and Amitiza.

See Also: Why do earnings reports matter?

Want to see what other hedge funds are holding MNK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mallinckrodt PLC (NYSE:MNK).

Institutional Ownership by Quarter for Mallinckrodt (NYSE:MNK)

Receive News & Ratings for Mallinckrodt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mallinckrodt and related companies with MarketBeat.com's FREE daily email newsletter.